Funded Projects
SFARI Funded Publications
Large multicenter randomized trials in autism: Key insights gained from the balovaptan clinical development program.
Jacob S., Anagnostou E., Hollander E., Jou R. J., McNamara N., Sikich L., Tobe R., Murphy D., McCracken J., Ashford E., Chatham C., Clinch S., Smith J., Sanders K., Murtagh L., Noeldeke J., Veenstra-VanderWeele J.
Efficacy and safety of balovaptan for socialisation and communication difficulties in autistic adults in North America and Europe: A phase 3, randomised, placebo-controlled trial.
Jacob S., Veenstra-VanderWeele J., Murphy D., McCracken J., Smith J., Sanders K., Meyenberg C., Wiese T., Deol-Bhullar G., Wandel C., Ashford E., Anagnostou E.
Whole blood serotonin levels and platelet 5-HT2a binding in autism spectrum disorder.
Aaron E., Montgomery A., Ren X., Guter S., Anderson G., Carneiro A.M.D., Jacob S., Mosconi M., Pandey G.N., Cook E. H., Veenstra-VanderWeele J.
